Navigation Links
FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Date:4/21/2011

that is a co-formulation of NKTR-118 and an opioid.  NKTR-181, a novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies.  In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.  NKTR-105, a novel anti-mitotic agent, is in a Phase 1 clinical study in cancer patients with refractory solid tumors.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Forward-Looking StatementsThis press release contains forward-looking statements that reflect management's current views regarding NKTR-102 and certain other drug candidates in Nektar’s pipeline.  These forward-looking statements involve numerous risks and uncertainties, including but not limited to: (i) Nektar's product candidates and those of its collaboration partners are in various stages of clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval for numerous reasons including safety and efficacy findings even after positive findings in preclinical and clinical studies; (ii) the timing of the commencement or end of clinical trials and the successful commercial launch of our drug candidates may be delayed or unsuccessful due to slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, reg
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
2. FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium
3. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
4. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
8. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
9. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
10. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
11. HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  Cohen, Placitella & Roth, PC is investigating ... Nymox Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 31, 2011 through November 2, 2014 ("Class Period").  ... its officers and directors publically disseminated materially false ... and 20(a) of the Securities Exchange Act of ...
(Date:11/26/2014)... -- Over 100 million adults suffer from chronic pain and ... Chronic and acute pain dramatically impacts quality of life. ... the need for non-surgical, interventional solutions and medication management ... October 28th, a new pain management center opened its ... community.  This new facility boasts cutting edge technologies and ...
(Date:11/26/2014)... , Nov. 26, 2014 Zynerba ... the development of innovative transdermal synthetic cannabinoid treatments, today ... Jaffray 26th Annual Healthcare Conference 2014. The conference will ... York Palace in New York . ... present at 4:50 pm on Tuesday, December 2. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... April 22 Genoptix, Inc. (Nasdaq: GXDX ), a specialized ... for the first quarter 2010 after closing of the NASDAQ Global Select Market ... , , ... , Ph.D., and other members of senior management will take place on the ...
... REDWOOD CITY, Calif. , April 22 Codexis, Inc. announced today ... stock, at $13.00 per share. All shares are being sold by ... an additional 900,000 shares at the initial public offering price to cover overallotments, ... the symbol "CDXS." , , , ...
Cached Medicine Technology:Genoptix, Inc. to Announce First Quarter 2010 Financial Results 2Genoptix, Inc. to Announce First Quarter 2010 Financial Results 3Codexis, Inc. Announces Pricing of Initial Public Offering 2
(Date:11/27/2014)... (PRWEB) November 27, 2014 Jeffrey ... years in the Charlotte area providing audits, reviews, ... services to businesses of varying size across numerous ... owners to meet all of their accounting and ... through the QuickBooks ProAdvisor Program. When asking Mr. ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VogueQueen.com is ... items for ladies across the world. As the premier ... accessories, VogueQueen.com is proud to release a huge selection ... high quality outfits, it is also providing many beautiful ... VogueQueen prom gowns at discounted prices. , “VogueQueen.com ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Dr. Ronald Receveur, ... has a few oral health tips before patients dig ... offers Louisville and New Albany affordable cosmetic dentistry, ... high in starch and sugar. While the staff wishes everyone ... helpful tips for how patients can enjoy a feast that ...
(Date:11/27/2014)... children to help with chores while they are home from ... boosts self-esteem, and above all, helps parents maintain a somewhat ... how do you encourage your children to want to help? ... Child Development Journal, there is. The study found that adults’ ... to lend a hand. , The study found that ...
(Date:11/27/2014)... Ethane Web Technologies, which is an ... reputation management service. , The company has designed ... world of internet marketing and algorithms of major search ... Web Technologies does not work with the same strategy ... to reach a conclusion what will work for the ...
Breaking Medicine News(10 mins):Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces Online Reputation Management Service 2
... reports little coronary benefit, regardless of when treatment begins , ... not lower the odds of heart trouble in women who ... of menopause, a new study reports. , In fact, the ... attacks for the first two years of use. , ...
... ... Awards (FOYA) were announced by the program’s sponsors, ISPE, INTERPHEX, and Pharmaceutical Processing ... their operations to yield top quality products. Two of this year’s winning companies ... ...
... ... Green” to the Next Level., , ... Tampa, FL (PRWEB) February 18, 2010 -- Super Green Technologies, ... tankless water heaters on the market today. Super Green Technologies water heaters utilize ...
... Van Andel Research Institute (VARI) researchers have found a ... currently the first line of defense against clear cell renal ... Most patients who show a positive response to sunitinib develop ... Kidney cancer is among the 10 most common cancers ...
... due to complications arising from pregnancy and childbirth. Half of ... the King Juan Carlos University (URJC) in Madrid says these ... but rather from a lack of basic healthcare measures. ... situation and of the inequalities between men and women", Jos ...
... ... Global Business to Business (B2B) Video Network , ... Toronto, Canada (PRWEB) February 18, 2010 -- BCS Global ... telepresence solutions, today announced that it has launched the PSVN (Public Switched Video Network) ...
Cached Medicine News:Health News:Early On, Hormone Therapy May Raise Women's Heart Risks 2Health News:Early On, Hormone Therapy May Raise Women's Heart Risks 3Health News:Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities 2Health News:First Breakthrough in Water Heating Technology! 2Health News:First Breakthrough in Water Heating Technology! 3Health News:VARI findings may help patients with deadly kidney cancer 2Health News:Most maternal deaths in sub-Saharan Africa could be avoided 2Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 2Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 3Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 4Health News:BCS Global Launches PSVN (Public Switched Video Network), an Initiative to Provide a Framework for Inter-Connecting Business to Business Video Networks 5
... flexible, total solution. , ,Kojair Tech Oy has ... A major part of our production is marketed ... the different areas of clean-air needs are a ... is a comprehensive supplier. We are able to ...
... 95% media meets today's ASHRAE ... contaminant reduction. The unique, patented ... DEFIANT filters creates a media ... respect to initial efficiency, average ...
The Universal Knee Positioner(s)™ reduces surgeon fatigue while assisting in the stabilization of a patient's leg during surgury....
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
Medicine Products: